Vivos Therapeutics, Inc. (VVOS)
VVOS Stock Price Chart
Explore Vivos Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze VVOS price movements and trends.
VVOS Company Profile
Discover essential business fundamentals and corporate details for Vivos Therapeutics, Inc. (VVOS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
11 Dec 2020
Employees
105.00
Website
https://www.vivos.comCEO
R. Kirk Huntsman
Description
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
VVOS Financial Timeline
Browse a chronological timeline of Vivos Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 18 Aug 2026
EPS estimate is -$0.42, while revenue estimate is $5.48m.
Earnings released on 20 May 2026
EPS came in at -$0.52 falling short of the estimated -$0.45 by -15.56%, while revenue for the quarter reached $5.14m , beating expectations by +18.22%.
Earnings released on 15 Apr 2026
EPS came in at -$0.58 falling short of the estimated -$0.50 by -17.17%, while revenue for the quarter reached $3.82m , missing expectations by -46.13%.
Earnings released on 19 Nov 2025
EPS came in at -$0.49 surpassing the estimated -$0.53 by +7.55%, while revenue for the quarter reached $6.78m , missing expectations by -4.42%.
Earnings released on 19 Aug 2025
EPS came in at -$0.55 falling short of the estimated -$0.27 by -103.70%, while revenue for the quarter reached $3.82m , beating expectations by +4.56%.
Earnings released on 15 May 2025
EPS came in at -$0.45 falling short of the estimated -$0.44 by -2.27%, while revenue for the quarter reached $3.02m , missing expectations by -17.74%.
Earnings released on 31 Mar 2025
EPS came in at -$0.28 surpassing the estimated -$0.43 by +34.88%, while revenue for the quarter reached $3.70m , missing expectations by -4.82%.
Earnings released on 14 Nov 2024
EPS came in at -$0.40 surpassing the estimated -$0.70 by +42.86%, while revenue for the quarter reached $3.86m , missing expectations by -0.65%.
Earnings released on 14 Aug 2024
EPS came in at -$0.60 surpassing the estimated -$1.05 by +42.86%, while revenue for the quarter reached $4.05m , beating expectations by +12.61%.
Earnings released on 14 May 2024
EPS came in at -$1.63 falling short of the estimated -$1.17 by -39.32%, while revenue for the quarter reached $3.42m , beating expectations by +0.26%.
Earnings released on 28 Mar 2024
EPS came in at -$3.05 falling short of the estimated -$1.90 by -60.53%, while revenue for the quarter reached $3.25m , missing expectations by -4.75%.
Earnings released on 14 Nov 2023
EPS came in at -$1.75 surpassing the estimated -$3.12 by +43.91%, while revenue for the quarter reached $3.30m , missing expectations by -26.64%.
Stock split effective on 27 Oct 2023
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 16 Aug 2023
EPS came in at -$3.75 matching the estimated -$3.75, while revenue for the quarter reached $3.40m , missing expectations by -18.00%.
Earnings released on 8 Jun 2023
EPS came in at -$5.00 falling short of the estimated -$4.25 by -17.65%, while revenue for the quarter reached $3.86m , missing expectations by -7.06%.
Earnings released on 30 Mar 2023
EPS came in at -$5.00 surpassing the estimated -$5.50 by +9.09%, while revenue for the quarter reached $3.95m , missing expectations by -6.97%.
Earnings released on 20 Dec 2022
EPS came in at -$8.25 falling short of the estimated -$0.28 by -2.85k%, while revenue for the quarter reached $4.25m , beating expectations by +14.10%.
Earnings released on 23 Aug 2022
EPS came in at -$8.27 , while revenue for the quarter reached $4.18m , beating expectations by +9.82%.
Earnings released on 16 May 2022
EPS came in at -$6.50 matching the estimated -$6.50, while revenue for the quarter reached $3.46m , missing expectations by -22.11%.
Earnings released on 31 Mar 2022
EPS came in at -$8.50 falling short of the estimated -$6.25 by -36.00%, while revenue for the quarter reached $4.40m , missing expectations by -9.28%.
Earnings released on 15 Nov 2021
EPS came in at -$6.50 falling short of the estimated -$4.00 by -62.50%, while revenue for the quarter reached $4.55m , beating expectations by +1.02%.
Earnings released on 12 Aug 2021
EPS came in at -$4.75 falling short of the estimated -$4.00 by -18.75%, while revenue for the quarter reached $4.50m , missing expectations by -0.01%.
VVOS Stock Performance
Access detailed VVOS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
